Madrigal Pharmaceuticals, Inc. MDGL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$288.28M+38.1% | -$465.89M-24.7% | -$373.63M-26.5% | -$295.35M-22.1% | ||
| $1.51M+37.4% | $1.1M+108% | $527K+12.8% | $467K+15.3% | ||
| $98.13M+22.8% | $79.88M+60.6% | $49.74M+57.3% | $31.63M+17.7% | ||
| —— | -$455.57M-40.5% | -$324.23M-44.2% | -$224.86M-22.3% | ||
| —— | $1.46M-1.1% | $1.48M+582% | $217K+3.8% | ||
| —— | -$274.39M+50.4% | -$552.72M-367% | $206.69M— | ||
| $255.98M-65.2% | $735.06M+23.5% | $595.12M+89.9% | $313.45M+83.1% | ||
| —— | —— | —— | $295.28M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Madrigal Pharmaceuticals, Inc. generate?
- Madrigal Pharmaceuticals, Inc. (MDGL) generated -$436.8M in operating cash flow over the trailing twelve months.
- What is Madrigal Pharmaceuticals, Inc.'s free cash flow?
- After $4.7M of capital expenditures, Madrigal Pharmaceuticals, Inc.'s free cash flow was -$440.3M over the trailing twelve months, up 3.7% year over year.
- Where does Madrigal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
